본문 바로가기
KERD
논문KCI 등재

남성 만성 조현병 환자에서 혈중 테스토스테론 농도와 인지 기능의 상관관계

The Association between Serum Testosterone Level and Cognitive Function in Men with Chronic Schizophrenia

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정신과학

초록

Objectives:The purpose of this study was to investigate the relationships between sexual hormone level and cognition in male patients with schizophrenia. Methods:Total 80 male patients with schizophrenia were involved in this study. Among them, 61 patients were classified into normal cognition group(NCG) and 19 patients for lower cognition group(LCG), according to the Korean version of Consortium to Establish a Registry for Alzheimer’s Disease(CERAD-K) and Korean-Color Word Stroop Test. LCG was identified who were included at the below 5 percentile in at least one domain of the cognitive test. All the participants completed Positive and Negative Syndrome Scale(PANSS), Simpson Angus rating Scales(SAS) and Hamilton rating scale for Depression(HAM-D). Sexual hormone levels of prolactin, total testosterone, free-testosterone and estradiol were also checked by blood hormonal assays. Results:The patients with higher total testosterone level on construction domain were more likely to be included in LCG than NCG. Statistically significant correlations were still observed after adjustment of the several covariants. Total testosterone, free testosterone and estradiol levels have statistically significant positive correlations between each other, but there were negative correlations between prolactin and other hormone levels in 80 male patients with schizophrenia. Conclusion:These results suggest that sexual hormone may modulate the cognitive deficits in patients with chronic schizophrenia. Sexual hormone levels would be considered as predictive factors about cognitive function of patients with chronic schizophrenia. Furthermore, longitudinal and large-scale control studies would be needed to confirm these results.

Abstract

Objectives:The purpose of this study was to investigate the relationships between sexual hormone level and cognition in male patients with schizophrenia. Methods:Total 80 male patients with schizophrenia were involved in this study. Among them, 61 patients were classified into normal cognition group(NCG) and 19 patients for lower cognition group(LCG), according to the Korean version of Consortium to Establish a Registry for Alzheimer’s Disease(CERAD-K) and Korean-Color Word Stroop Test. LCG was identified who were included at the below 5 percentile in at least one domain of the cognitive test. All the participants completed Positive and Negative Syndrome Scale(PANSS), Simpson Angus rating Scales(SAS) and Hamilton rating scale for Depression(HAM-D). Sexual hormone levels of prolactin, total testosterone, free-testosterone and estradiol were also checked by blood hormonal assays. Results:The patients with higher total testosterone level on construction domain were more likely to be included in LCG than NCG. Statistically significant correlations were still observed after adjustment of the several covariants. Total testosterone, free testosterone and estradiol levels have statistically significant positive correlations between each other, but there were negative correlations between prolactin and other hormone levels in 80 male patients with schizophrenia. Conclusion:These results suggest that sexual hormone may modulate the cognitive deficits in patients with chronic schizophrenia. Sexual hormone levels would be considered as predictive factors about cognitive function of patients with chronic schizophrenia. Furthermore, longitudinal and large-scale control studies would be needed to confirm these results.

참고문헌 (45)

  1. McGrath J, "Schizophrenia: a concise overview of incidence, prevalence, and mortality", Epidemiol Rev, 30, pp.67~76 (2008)
  2. Abel KM, "Sex differences in schizophrenia", Int Rev Psychiatry, 22, pp.417~428 (2010)
  3. Green MF, "Cognition in schizophrenia: Past, present, and future", Schizophr Res Cogn, 1, pp.e1~e9 (2014)
  4. Maat A, "Social cognition and quality of life in schizophrenia", Schizophr Res, 137, pp.212~218 (2012)
  5. Harvey PD, "Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia", Schizophr Res, 66, pp.101~113 (2004)
  6. de Bartolomeis A, "Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses", Psychiatry Res, 210, pp.387~395 (2013)
  7. Rathod S, "Cognitive Behavioral Therapy for Schizophrenia", Psychiatr Clin North Am, 33, pp.527~536 (2010)
  8. Garrido G, "Computer-assisted cognitive remediation therapy: Cognition, self-esteem and quality of life in schizophrenia", Schizophr Res, 150, pp.563~569 (2013)
  9. Brann DW, "Neurotrophic and neuroprotective actions of estrogen : Basic mechanisms and clinical implications", Steroids, 72, pp.381~405 (2007)
  10. Pike CJ, "Protective actions of sex steroid hormones in Alzheimer’s disease", Front Neuroendocrinol, 30, pp.239~258 (2009)
  11. Sherwin BB., "Steroid hormones and cognitive functioning in aging men : a mini-review", J Mol Neurosci, 20, pp.385~393 (2003)
  12. Matousek RH, "Sex steroid hormones and cognitive functioning in healthy, older men", Horm Behav, 57, pp.352~359 (2010)
  13. Cherrier MM, "Testosterone supplementation improves spatial and verbal memory in healthy older men", Neurology, 57, pp.80~88 (2001)
  14. Cherrier MM, "Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men", Psychoneuroendocrinology, 32, pp.72~79 (2007)
  15. Holland J, "Testosterone levels and cognition in elderly men : A review", Maturitas, 69, pp.322~337 (2011)
  16. Akhondzadeh S, "Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia", Schizophr Res, 84, pp.405~410 (2006)
  17. Ko YH, "Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia", Psychoneuroendocrinology, 32, pp.385~391 (2007)
  18. Moore L, "Serum testosterone levels are related to cognitive function in men with schizophrenia", Psychoneuroendocrinology, 38, pp.1717~1728 (2013)
  19. 이중서, "한국판 양성 및 음성증후군 척도(Positive and Negative Syndrome Scale)의 신뢰도와 타당도", 신경정신의학, 40(6), pp.1090~1105 (2001), 대한신경정신의학회
  20. Simpson GM, "A rating scale for extrapyramidal side effects", Acta Psychiatr Scand Suppl, 212, pp.11~19 (1970)
  21. Lee JH, "Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K): clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.P47~P53 (2002)
  22. Shin MS, "Stroop Color and Word Test, a Manual for Clinical and Experimental Uses", pp.91~ (2007), Hakjisa
  23. Lezak MD, "Neuropsychological assessement", pp.1056~ (1995), Oxford University Press
  24. Nuechterlein KH, "The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity", Am J Psychiatry, 165, pp.203~213 (2008)
  25. 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구", 신경정신의학, 44(4), pp.456~465 (2005), 대한신경정신의학회
  26. Gardner DM, "International consensus study of antipsychotic dosing", Am J Psychiatry, 167, pp.686~693 (2010)
  27. Petersen RC, "Mild cognitive impairment : clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
  28. McKhann G, "Clinical diagnosis of Alzheimer’s disease Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
  29. Montalvo I, "Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis", PLoS One, 9, pp.e89428~ (2014)
  30. Torner L, "Hyperprolactinemia impairs object recognition without altering spatial learning in male rats", Behav Brain Res, 252, pp.32~39 (2013)
  31. Muller M, "Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level?", Neurology, 64, pp.866~871 (2005)
  32. Martin DM, "Endogenous testosterone levels, mental rotation performance, and constituent abilities in middle-to-older aged men", Horm Behav, 53, pp.431~441 (2008)
  33. Van Strien JW, "Higher free testosterone level is associated with faster visual processing and more flanker interference in older men", Psychoneuroendocrinology, 34, pp.546~554 (2009)
  34. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute scientific statement: Executive Summary, 2005, pp.4, 198~203
  35. Lim S, "Increasing Prevalence of Metabolic Syndrome in Korea The Korean National Health and Nutrition Examination Survey for 1998-2007", Diabetes Care, 34, pp.1323~1328 (2011)
  36. Lee SJ, "Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications", Annu Rev Pharmacol Toxicol, 41, pp.569~591 (2001)
  37. Bicknell RJ, "Sex-steroid action on neurotransmission", Curr Opin Neurol, 11, pp.667~671 (1998)
  38. Behl C, "Sex hormones, neuroprotection and cognition", Prog Brain Res, 138, pp.135~142 (2002)
  39. Garcia-Segura LM, "Neuroprotection by estradiol", Prog Neurobiol, 63, pp.29~60 (2001)
  40. Halbreich U, "Elevated prolactin levels in patients with schizophrenia : mechanisms and related adverse effects", Psychoneuroendocrinology, 28(Suppl 1), pp.53~67 (2003)
  41. Gooren LJ, "Significance of oestrogens in male(patho)physiology", Ann Endocrinol, 64, pp.126~135 (2003)
  42. Vermeulen A, "Estradiol in elderly men", Aging Male, 5, pp.98~102 (2002)
  43. Dunn JF, "Transport of steroid hormones : binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma", J Clin Endocrinol Metab, 53, pp.58~68 (1981)
  44. Byerly M, "Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders : recent developments and current perspectives", J Clin Psychopharmacol, 27, pp.639~661 (2007)
  45. Besnard I, "Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance", Encephale, 40, pp.86~94 (2014)

관련 논문AI추천

조현병 환자에서 정신병리와 인지 기능과의 연관성강제욱, 공보금, 김성진, 김연수, 김임규, 문정준, 심주철, 오민경, 임지섭, 정도운대한생물치료정신의학회 · 생물치료정신의학2013 · 제19권 제2호조현병 환자에서 성별에 따른 인지기능의 차이박경환, 신예은, 최말례, 한명일대한조현병학회 · 대한조현병학회지2024 · 제27권 제2호노인 만성 조현병 환자군에서 병태생리, 인지기능, 병식, 삶의 질 간의 관련성김정민, 나의현, 이준노, 임선진, 한혜리, 홍경기, 홍문화대한노인정신의학회 · 노인정신의학2014 · 제18권 제2호The Association Between Prolactin Levels and Cognitive Function in Female Patients With Severe Mental DisordersDonghong Cui, Lijun Wang, Shun Yao, Xiaoqing Zhang, Yichong Xu, Yuan Shi, Zhiying Yang대한신경정신의학회 · PSYCHIATRY INVESTIGATION2024 · 제21권 제8호조현병 환자에서 성기능 장애의 유병률과 양상에 관한 대조군 비교 연구백대업, 윤지환, 이경환, 장세헌, 제영묘, 최진혁대한생물치료정신의학회 · 생물치료정신의학2021 · 제27권 제2호항정신병약물을 복용중인 정신분열병 환자에서 고프로락틴혈증과 무월경 유병률 및 성기능 장애와 관련성강권영, 강시현, 김경훈, 김권곤, 소민아, 안길준, 이가희, 이종일대한신경정신의학회 · 신경정신의학2009 · 제48권 제6호

이 간행물의 다른 논문 (8건)